88 related articles for article (PubMed ID: 2193699)
1. Capsules and virulence in the HAP group of bacteria.
Inzana TJ
Can J Vet Res; 1990 Apr; 54 Suppl():S22-7. PubMed ID: 2193699
[TBL] [Abstract][Full Text] [Related]
2. Overview of the virulence attributes of the HAP-group of bacteria.
Nicolet J
Can J Vet Res; 1990 Apr; 54 Suppl():S12-5. PubMed ID: 2193698
[TBL] [Abstract][Full Text] [Related]
3. Haemophilus influenzae: surface antigens and aspects of virulence.
Munson RS
Can J Vet Res; 1990 Apr; 54 Suppl():S63-7. PubMed ID: 2193707
[TBL] [Abstract][Full Text] [Related]
4. Actinobacillus pleuropneumoniae: molecular aspects of virulence and pulmonary injury.
Bertram TA
Can J Vet Res; 1990 Apr; 54 Suppl():S53-6. PubMed ID: 2193705
[TBL] [Abstract][Full Text] [Related]
5. Interactions of Haemophilus-Actinobacillus-Pasteurella bacteria with phagocytic cells.
Czuprynski CJ; Sample AK
Can J Vet Res; 1990 Apr; 54 Suppl():S36-40. PubMed ID: 2193702
[TBL] [Abstract][Full Text] [Related]
6. Virulence properties and protective efficacy of the capsular polymer of Haemophilus (Actinobacillus) pleuropneumoniae serotype 5.
Inzana TJ; Ma J; Workman T; Gogolewski RP; Anderson P
Infect Immun; 1988 Aug; 56(8):1880-9. PubMed ID: 3397178
[TBL] [Abstract][Full Text] [Related]
7. Positive and negative aspects of host immune response to Haemophilus, Actinobacillus and Pasteurella.
Stephens LR
Can J Vet Res; 1990 Apr; 54 Suppl():S41-4. PubMed ID: 2193703
[TBL] [Abstract][Full Text] [Related]
8. Resistance of Actinobacillus pleuropneumoniae to bactericidal antibody and complement is mediated by capsular polysaccharide and blocking antibody specific for lipopolysaccharide.
Ward CK; Inzana TJ
J Immunol; 1994 Sep; 153(5):2110-21. PubMed ID: 8051416
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of a novel capsule-associated lipoprotein among pasteurellaceae pathogenic in animals.
Champlin FR; Shryock TR; Patterson CE; Austin FW; Ryals PE
Curr Microbiol; 2002 Apr; 44(4):297-301. PubMed ID: 11910502
[TBL] [Abstract][Full Text] [Related]
10. Our understanding of the Pasteurellaceae.
Biberstein EL
Can J Vet Res; 1990 Apr; 54 Suppl():S78-82. PubMed ID: 2193710
[TBL] [Abstract][Full Text] [Related]
11. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
Lindberg AA; Weintraub A
Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
[TBL] [Abstract][Full Text] [Related]
12. Identification of genes involved in biosynthesis of Actinobacillus pleuropneumoniae serotype 1 O-antigen and biological properties of rough mutants.
Labrie J; Rioux S; Wade MM; Champlin FR; Holman SC; Wilson WW; Savoye C; Kobisch M; Sirois M; Galarneau C; Jacques M
J Endotoxin Res; 2002; 8(1):27-38. PubMed ID: 11981443
[TBL] [Abstract][Full Text] [Related]
13. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. V. In vivo expression of individual antibody clones is dependent on Ig CH haplotypes and the categories of antigen.
Chung GH; Scott MG; Kim KH; Kearney J; Siber GR; Ambrosino DM; Nahm MH
J Immunol; 1993 Oct; 151(8):4352-61. PubMed ID: 8409407
[TBL] [Abstract][Full Text] [Related]
14. Influence of the Escherichia coli capsule on complement fixation and on phagocytosis and killing by human phagocytes.
Horwitz MA; Silverstein SC
J Clin Invest; 1980 Jan; 65(1):82-94. PubMed ID: 6985617
[TBL] [Abstract][Full Text] [Related]
15. Virulence attributes of the liposaccharides of the HAP group organisms.
Fenwick BW
Can J Vet Res; 1990 Apr; 54 Suppl():S28-32. PubMed ID: 2193700
[TBL] [Abstract][Full Text] [Related]
16. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
[TBL] [Abstract][Full Text] [Related]
17. [Immunological principles of polysaccharide-protein conjugate vaccination].
Meyer M; Gahr M
Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
[TBL] [Abstract][Full Text] [Related]
18. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection.
Colino J; Outschoorn I
Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459
[TBL] [Abstract][Full Text] [Related]
19. [What makes bacteria pathogenic?].
Vorland LH
Tidsskr Nor Laegeforen; 2001 Oct; 121(26):3083-9. PubMed ID: 11757445
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vivo and in vitro analyses of putative virulence factors of Burkholderia pseudomallei using lipopolysaccharide, capsule and flagellin mutants.
Wikraiphat C; Charoensap J; Utaisincharoen P; Wongratanacheewin S; Taweechaisupapong S; Woods DE; Bolscher JG; Sirisinha S
FEMS Immunol Med Microbiol; 2009 Aug; 56(3):253-9. PubMed ID: 19549172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
